Extracorpor acorporeal Membr eal Membrane Oxy ane Oxygenation Ther genation Therapy in CO y in COVID-19 Patients with Acute Respir atients with Acute Respiratory Distr y Distress Syndr ess Syndrome
Journal of Shock and Hemodynamics · 2022
DOI: 10.57905/josh/e2022111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Shock and Hemodynamics, 2022. Verfasst von Joseph Zwischenberger und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Patients with coronavirus disease of 2019 (COVID-19) may present with a wide range of symptoms ranging from asymptomatic to critically ill. Approximately 10-14% of patients require hospitalization. Those individuals requiring hospitalization can deteriorate rapidly with worsening hypoxemia or new-onset pneumonia, resulting in 20-30% of patients developing acute respiratory distress syndrome (ARDS). When refractory to medical management, severe ARDS secondary to other illnesses has been successfully treated with extracorporeal membrane oxygenation (ECMO). We completed a comprehensive literature review of ECMO utilization for patients with severe COVID-19 who were unresponsive to critical care management. Of the 1419 patients with a reported diagnosis of COVID-19-related ARDS requiring ECMO therapy, 53.6% were discharged alive, 8.4% remained on ECMO in the intensive care unit, and 43.0% are deceased. These results are similar to the discharge rate of 60% for patients with non-COVID-related ARDS treated with ECMO. Data reported by the Extracorporeal Life Support Organization notes that 49% of patients with COVID-19 ARDS were discharged alive, 38% of whom were discharged home or to a long-term facility, and 11% were discharged to another hospital. In summary, using ECMO to treat patients with severe ARDS unresponsive to critical care management yields similar results in both non-COVID and COVID-related ARDS.
Zitieren
APA
Zwischenberger, J., & Breetz, K. (2022). Extracorpor acorporeal Membr eal Membrane Oxy ane Oxygenation Ther genation Therapy in CO y in COVID-19 Patients with Acute Respir atients with Acute Respiratory Distr y Distress Syndr ess Syndrome. Journal of Shock and Hemodynamics. https://doi.org/10.57905/josh/e2022111
Vancouver
Zwischenberger J, Breetz K. Extracorpor acorporeal Membr eal Membrane Oxy ane Oxygenation Ther genation Therapy in CO y in COVID-19 Patients with Acute Respir atients with Acute Respiratory Distr y Distress Syndr ess Syndrome. Journal of Shock and Hemodynamics. 2022. doi:10.57905/josh/e2022111
BibTeX
@article{Zwischenberger2022,
author = {Zwischenberger, Joseph and Breetz, Katherine},
title = {Extracorpor acorporeal Membr eal Membrane Oxy ane Oxygenation Ther genation Therapy in CO y in COVID-19 Patients with Acute Respir atients with Acute Respiratory Distr y Distress Syndr ess Syndrome},
journal = {Journal of Shock and Hemodynamics},
year = {2022},
doi = {10.57905/josh/e2022111}
}
EUVIMED